Finally, CDK5 phosphorylated and stabilized PES1, and Dinaciclib was proven to down-regulate PES1 and overcome pancreatic cancer cell resistance to JQ1 (Fig. 7). Here, CDK5 is linked to familial pancreatic carcinoma.